Healthcare & Life Sciences News and Articles

Google News – FDA (biotech/pharma) External News

Pharma and biotech innovation and competition in 2026: Five areas to watch - hlc.com

news.google.com · 03 Jul 2026

Google News – EMA (biotech/pharma) External News

LSD therapy biotech Definium fends off trade-secret lawsuit - Reuters

news.google.com · 02 Jul 2026

Google News – FDA (biotech/pharma) External News

A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong - STAT

news.google.com · 02 Jul 2026

Google News – FDA (biotech/pharma) External News

Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States - Business Wire

news.google.com · 01 Jul 2026

Google News – FDA (biotech/pharma) External News

Sanofi unit in Ireland chided by FDA over manufacturing flubs linked to Altuviiio - Fierce Pharma

news.google.com · 01 Jul 2026

Google News – WHO External News

WHO Health Emergencies EPI-WIN webinar: New WHO guidance on bacterial meningitis: a tool for frontline healthcare workers - World Health Organization (WHO)

news.google.com · 30 Jun 2026

Google News – Clinical Trials External News

PARADIGM HEALTH SUBMITS RESPONSE TO FDA'S REAL-TIME CLINICAL TRIALS INITIATIVE RFI, INFORMED BY BIOPHARMA SPONSORS AND PROVIDERS - prnewswire.com

news.google.com · 30 Jun 2026

Google News – FDA (biotech/pharma) External News

FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program - Fierce Pharma

news.google.com · 30 Jun 2026

Google News – Biopharma External News

China’s Burgeoning Biopharmaceutical Competitiveness Demands a US Response | Reports & Briefings | Jun 29, 2026 - Information Technology and Innovation Foundation

news.google.com · 29 Jun 2026

Google News – FDA (biotech/pharma) External News

Pharmalittle: We're reading about a broader $35 insulin cap, a former FDA cancer drug chief, and more - STAT

news.google.com · 29 Jun 2026

Industry News External News

Takeda's 1st female CEO leans into AI to shape biopharma business - Nikkei Asia

news.google.com · 27 Jun 2026

Google News – EMA (biotech/pharma) External News

EMA committee issues negative opinion on MaaT Pharma’s MaaT013 - Investing.com

news.google.com · 26 Jun 2026

Google News – EMA (biotech/pharma) External News

MaaT Pharma: EMA Issues Negative Opinion on Xervyteg, Reassessment Requested - Idéal Investisseur

news.google.com · 26 Jun 2026

Google News – EMA (biotech/pharma) External News

Latest CHMP decisions led by recommendation to revoke approval of Tavneos - FirstWord Pharma

news.google.com · 26 Jun 2026

Google News – EMA (biotech/pharma) External News

MaaT Pharma Announces Plan to Request Re-Examination Following Negative CHMP Opinion for MaaT013 for the treatment of acute Graft-versus-Host Disease - businesswire.com

news.google.com · 26 Jun 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Pharma and biotech innovation and competition in 2026: Five areas to watch - hlc.com

LSD therapy biotech Definium fends off trade-secret lawsuit - Reuters

A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong - STAT

Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States - Business Wire

Sanofi unit in Ireland chided by FDA over manufacturing flubs linked to Altuviiio - Fierce Pharma

WHO Health Emergencies EPI-WIN webinar: New WHO guidance on bacterial meningitis: a tool for frontline healthcare workers - World Health Organization (WHO)

PARADIGM HEALTH SUBMITS RESPONSE TO FDA'S REAL-TIME CLINICAL TRIALS INITIATIVE RFI, INFORMED BY BIOPHARMA SPONSORS AND PROVIDERS - prnewswire.com

FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program - Fierce Pharma

China’s Burgeoning Biopharmaceutical Competitiveness Demands a US Response | Reports & Briefings | Jun 29, 2026 - Information Technology and Innovation Foundation

Pharmalittle: We're reading about a broader $35 insulin cap, a former FDA cancer drug chief, and more - STAT

Takeda's 1st female CEO leans into AI to shape biopharma business - Nikkei Asia

EMA committee issues negative opinion on MaaT Pharma’s MaaT013 - Investing.com

MaaT Pharma: EMA Issues Negative Opinion on Xervyteg, Reassessment Requested - Idéal Investisseur

Latest CHMP decisions led by recommendation to revoke approval of Tavneos - FirstWord Pharma

MaaT Pharma Announces Plan to Request Re-Examination Following Negative CHMP Opinion for MaaT013 for the treatment of acute Graft-versus-Host Disease - businesswire.com